Headlines about Omnicare (NYSE:OCR) have been trending somewhat positive this week, according to Accern. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Omnicare earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave media headlines about the healthcare company an impact score of 44.433498432976 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Shares of Omnicare (NYSE OCR) opened at $97.90 on Friday. The firm has a market cap of $9,480.00 and a PE ratio of 60.06.

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/omnicare-ocr-receiving-somewhat-favorable-news-coverage-report-shows/1859029.html.

Omnicare Company Profile

Omnicare, Inc is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings.

Receive News & Ratings for Omnicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicare and related companies with MarketBeat.com's FREE daily email newsletter.